ADIPOKINE AND CYTOKINE PROFILES IN METABOLIC SYNDROME: EFFECTS OF LEPTIN, ADIPONECTIN, AND GHRELIN ON ENZYMES OF LIPID AND CARBOHYDRATE METABOLISM

Metabolic syndrome represents a cluster of interrelated cardiometabolic disturbances driven by visceral adiposity, chronic low-grade inflammation, and systemic insulin resistance. Central to this pathophysiology is a disrupted endocrine crosstalk between adipose-derived adipokines, pro-inflammatory cytokines, and gastrointestinal peptide hormones that directly modulate key rate-limiting enzymes of lipid and carbohydrate metabolism. This structured IMRAD literature review, prepared at the Department of Biological Chemistry of Andijan State Medical Institute, synthesizes contemporary biochemical and molecular evidence regarding the adipokine-cytokine profile in metabolic syndrome, focusing specifically on how leptin, adiponectin, and ghrelin regulate enzymatic pathways. Under physiological conditions, leptin and adiponectin activate AMP-activated protein kinase (AMPK) in skeletal muscle and liver, phosphorylating and inhibiting acetyl-CoA carboxylase (ACC) to relieve malonyl-CoA inhibition of carnitine palmitoyltransferase-1 (CPT-1) and stimulate mitochondrial fatty acid beta-oxidation. Simultaneously, adiponectin suppresses hepatic gluconeogenic enzymes—phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase)—and activates receptor-associated ceramidase. In metabolic syndrome, however, visceral fat expansion elevates tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β), inducing suppressor of cytokine signaling-3 (SOCS-3) and c-Jun N-terminal kinase (JNK1) pathways that trigger leptin resistance, hypoadiponectinemia, and suppressed acylated ghrelin signaling. Understanding these enzymatic and endocrine shifts provides critical diagnostic biomarkers and targeted biochemical strategies for managing metabolic syndrome.

Authors

Publication Details

Journal
Arabian journal of science.
Published
2026-11-18
Primary Topic
Adipokines, Inflammation, and Metabolic Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

ADIPOKINE AND CYTOKINE PROFILES IN METABOLIC SYNDROME: EFFECTS OF LEPTIN, ADIPONECTIN, AND GHRELIN ON ENZYMES OF LIPID AND CARBOHYDRATE METABOLISM

Ma'murjonova Durdona Ma'murjon qizi
Arabian journal of science.
Adipokines, Inflammation, and Metabolic Diseases
article

ADIPOKINE AND CYTOKINE PROFILES IN METABOLIC SYNDROME: EFFECTS OF LEPTIN, ADIPONECTIN, AND GHRELIN ON ENZYMES OF LIPID AND CARBOHYDRATE METABOLISM

Ma'murjonova Durdona Ma'murjon qizi
article en

Abstract

Metabolic syndrome represents a cluster of interrelated cardiometabolic disturbances driven by visceral adiposity, chronic low-grade inflammation, and systemic insulin resistance. Central to this pathophysiology is a disrupted endocrine crosstalk between adipose-derived adipokines, pro-inflammatory cytokines, and gastrointestinal peptide hormones that directly modulate key rate-limiting enzymes of lipid and carbohydrate metabolism. This structured IMRAD literature review, prepared at the Department of Biological Chemistry of Andijan State Medical Institute, synthesizes contemporary biochemical and molecular evidence regarding the adipokine-cytokine profile in metabolic syndrome, focusing specifically on how leptin, adiponectin, and ghrelin regulate enzymatic pathways. Under physiological conditions, leptin and adiponectin activate AMP-activated protein kinase (AMPK) in skeletal muscle and liver, phosphorylating and inhibiting acetyl-CoA carboxylase (ACC) to relieve malonyl-CoA inhibition of carnitine palmitoyltransferase-1 (CPT-1) and stimulate mitochondrial fatty acid beta-oxidation. Simultaneously, adiponectin suppresses hepatic gluconeogenic enzymes—phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase)—and activates receptor-associated ceramidase. In metabolic syndrome, however, visceral fat expansion elevates tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β), inducing suppressor of cytokine signaling-3 (SOCS-3) and c-Jun N-terminal kinase (JNK1) pathways that trigger leptin resistance, hypoadiponectinemia, and suppressed acylated ghrelin signaling. Understanding these enzymatic and endocrine shifts provides critical diagnostic biomarkers and targeted biochemical strategies for managing metabolic syndrome.

Arabian journal of science.
Adipokines, Inflammation, and Metabolic Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon